The association between maternal human papillomavirus (HPV) experiences and HPV vaccination of their children

Figures & data

Table 1. Descriptive and bivariate logistic results

	X (SD) or % (N)	HPV vaccination uptake (1 or more doses)	OR (95% CI)
Child received 1 or more doses of HPV vaccine Yes No	396 (36%) 701 (64%)
Child’s age 9–10 years old 11–13 years old	50% (594) 50% (588)	41% (162) 59% (234)	ref 1.75 (1.36, 2.24)
Child’s sex Female Male	59% (702) 41% (482)	64% (255) 36% (141)	1.31 (1.02, 1.70) ref
Maternal age	37.5 (8.033)	37.7 (7.801)	.98 (.96,.99)
Income $24,999 or less $25,000-$74,999 $75,000 or more	17% (187) 52% (589) 31% (347)	18% (67) 51% (193) 31% (119)	ref.79 (.55, 1.13).79 (.54, 1.17)
Maternal history of abnormal Pap smear Yes No	36% (384) 64% (684)	42% (144) 58% (195)	1.50 (1.15, 1.97) ref
Family/friend history of cervical cancer Yes No	18% (211) 82% (935)	24% (92) 76% (290)	1.72 (1.26, 2.35) ref
Maternal history of cervical cancer Cervical cancer diagnosis Never diagnosed	6% (70) 94% (1085)	11% (42) 89% (342)	3.00 (1.82, 4.95) ref

Abbreviations:X = mean, SD = Standard Deviation, N = number, OR = Odds Ratio, CI = Confidence Interval

Figure 1. Perceived benefits mediates the relationship between history of abnormal Pap smear and HPV vaccination uptake

Figure 2. Perceived benefits mediates the relationship between family/friend history of cervical cancer and HPV vaccination uptake

Figure 3. Perceived benefits mediates the relationship between maternal history of cervical cancer and HPV vaccination uptake